CRNX
Price
$41.43
Change
-$1.39 (-3.25%)
Updated
Nov 13 closing price
Capitalization
3.93B
110 days until earnings call
Intraday BUY SELL Signals
VERA
Price
$28.37
Change
-$2.71 (-8.72%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
1.98B
126 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRNX vs VERA

Header iconCRNX vs VERA Comparison
Open Charts CRNX vs VERABanner chart's image
Crinetics Pharmaceuticals
Price$41.43
Change-$1.39 (-3.25%)
Volume$1.98M
Capitalization3.93B
Vera Therapeutics
Price$28.37
Change-$2.71 (-8.72%)
Volume$17.52K
Capitalization1.98B
CRNX vs VERA Comparison Chart in %
CRNX
Daily Signal:
Gain/Loss:
VERA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRNX vs. VERA commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and VERA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CRNX: $42.82 vs. VERA: $31.08)
Brand notoriety: CRNX and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 152% vs. VERA: 171%
Market capitalization -- CRNX: $3.93B vs. VERA: $1.81B
CRNX [@Biotechnology] is valued at $3.93B. VERA’s [@Biotechnology] market capitalization is $1.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, VERA is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 3 TA indicator(s) are bullish while VERA’s TA Score has 8 bullish TA indicator(s).

  • CRNX’s TA Score: 3 bullish, 5 bearish.
  • VERA’s TA Score: 8 bullish, 3 bearish.
According to our system of comparison, VERA is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а +0.68% price change this week, while VERA (@Biotechnology) price change was +28.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

CRNX is expected to report earnings on Mar 04, 2026.

VERA is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.93B) has a higher market cap than VERA($1.98B). CRNX YTD gains are higher at: -16.253 vs. VERA (-26.507). VERA has higher annual earnings (EBITDA): -210.52M vs. CRNX (-419.62M). CRNX has more cash in the bank: 1.2B vs. VERA (557M). CRNX has less debt than VERA: CRNX (49.9M) vs VERA (77.6M). CRNX has higher revenues than VERA: CRNX (1.39M) vs VERA (0).
CRNXVERACRNX / VERA
Capitalization3.93B1.98B198%
EBITDA-419.62M-210.52M199%
Gain YTD-16.253-26.50761%
P/E RatioN/AN/A-
Revenue1.39M0-
Total Cash1.2B557M215%
Total Debt49.9M77.6M64%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
55
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXVERA
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
75%
Bearish Trend 9 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signal:
Gain/Loss:
VERA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAKIX32.340.28
+0.87%
Oakmark International Investor
SMVIX23.590.11
+0.47%
SEI Small Cap Value I (SIMT)
CMUAX14.940.04
+0.27%
Columbia Select Mid Cap Value A
AOFIX21.34-0.10
-0.47%
Alger Small Cap Focus I
GRERX10.89-0.09
-0.82%
Goldman Sachs Real Estate Securities R

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-0.28%
XNCR - CRNX
59%
Loosely correlated
-3.23%
NUVL - CRNX
53%
Loosely correlated
+0.91%
IDYA - CRNX
53%
Loosely correlated
-0.19%
CLDX - CRNX
53%
Loosely correlated
-0.49%
NRIX - CRNX
52%
Loosely correlated
-5.37%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
+4.61%
KYMR - VERA
60%
Loosely correlated
+0.25%
LYRA - VERA
53%
Loosely correlated
-8.49%
VYGR - VERA
41%
Loosely correlated
-0.23%
CRNX - VERA
41%
Loosely correlated
-0.28%
IMTX - VERA
40%
Loosely correlated
+16.10%
More